✦ LIBER ✦

Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb/IIIa inhibition during carotid stenting

✍ Scribed by Albert W. Chan; Jay S. Yadav; Deepak L. Bhatt; Christopher T. Bajzer; Patricia A. Gum; Marco Roffi; Leslie Cho; Ramtin Agah; Eric J. Topol

Book ID: 113441762
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 91 KB
Volume: 95
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2004.11.041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the safety and efficacy of

Comparison of the safety and efficacy of the use of emboli protection device versus glycoprotein IIb/IIIa inhibitor during carotid stenting

✍ Albert W. Chan; Deepak L. Bhatt; Christopher T. Bajzer; Eric J. Topol; Jay S. Ya 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 323 KB

THE EFFICACY AND SAFETY OF TICAGRELOR AS

THE EFFICACY AND SAFETY OF TICAGRELOR AS COMPARED TO CLOPIDOGREL, WITH AND WITHOUT A GLYCOPROTEIN IIB/IIIA INHIBITOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS INTERVENTION: A PLATO (STUDY OF PLATELET INHIBITION AND PATIENT OUTCOMES) ANALYSIS

✍ Bansilal, Sameer; Wiviott, Stephen; Becker, Richard; Harrington, Robert; Himmelm 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 249 KB

The Efficacy and Safety of Prasugrel Wit

The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38) Analysis

✍ Michelle O'Donoghue; Elliott M. Antman; Eugene Braunwald; Sabina A. Murphy; P. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 480 KB